This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Kinam Hong
Partner at Sofinnova Partners


Kinam joined Sofinnova Partners in January 2017 as a partner driving Sofinnova’s later-stage, crossover investment strategy. Prior to joining Sofinnova Partners, Kinam was a co-manager of the Exane Equinox fund, a global healthcare fund backing later-stage, public biotechnology companies. Before that, he spent 10 years as an investor and analyst covering the biotechnology sector, including at Citigroup Investment Research, where he specialized in small- and mid-cap biotechnology companies. Prior to his investment career, Kinam worked in new product development at Sanofi, the multinational pharmaceutical company, where he held various roles in product development, business development and strategic marketing, working on infectious diseases and oncology licensing deals, and on the company’s China strategy. Kinam is a physician and scientist, holding degrees in molecular biology/biochemistry and medicine from the University of Florida. He also holds a CFA (Chartered Financial Analyst) and MBA from INSEAD (France).

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future. Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €2.5 billion under management. For more information, please visit:

Agenda Sessions

  • Day in the life of an experienced dealmaker